TIS 0.00% 0.0¢ tissue therapies limited

Mention in Australian, page-5

  1. 427 Posts.
    lightbulb Created with Sketch. 7
    It may not have fast tracked the CE process, but the vitrogro may be in use and supplying valuable information. Some of that information may have been about the safety of the product, and it success in its ability. Such data and information takes some of the strain off others shoulders when they have to make a decision regarding an unknown. It wasn't perused in Oz because no one in their wildest dreams expected it to take as long as it has. Remember 2 years ago and when people were saying it may take till Christmas to get it through and others were flapping their arms about "Baseless" predictions.
    My concern at the moment is that after more than a few months to supply all the information required for the questions asked, the company was unable to. There is a sticking point, and I bet it is around the issue of the ancillary aspect (growth factors) that caused the EMA to refute the classification in the first place.
    I can't be at the meeting, but I hope others can push for information. Last year was a joke, that the next day they announced a capital raising. This management is always hiding in the shadows.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.